LORI FOSTER: Open Payments
NPI 1871584102 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 59 payments from 24 companies in 2025. Trend: 2023 $1,879 · 2024 $1,832 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $168 |
| Novo Nordisk Inc | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 9 | $138 |
| ABBVIE INC. | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 3 | $88 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Dexcom, Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Amgen Inc. | 2 | $30 |
Products named: QULIPTA, PREVNAR 20, SPRAVATO, Ozempic, NURTEC ODT, Wegovy, BREZTRI, FARXIGA.
Industry payments across VA — which companies pay providers there.
